Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-017714
Filing Date
2020-06-25
Accepted
2020-06-25 20:05:58
Documents
2
Period of Report
2020-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 7704
2 EX-24 DOCUMENT attachment1.htm EX-24 4720
  Complete submission text file 0000899243-20-017714.txt   13808
Mailing Address C/O ODLANDER, FREDRIKSON & CO. AB STRANDVAGEN 5B STOCKHOLM V7 SE-114 51
Business Address
Christenson Johan (Reporting) CIK: 0001488771 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-39344 | Film No.: 20990654

Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Issuer) CIK: 0001805890 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)